Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Intravenous (IV) Ibuprofen market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Intravenous (IV) Ibuprofen market segmented into
Pain/Inflammatory
Fever
Based on the end-use, the global Intravenous (IV) Ibuprofen market classified into
Pediatrics
Adults
Based on geography, the global Intravenous (IV) Ibuprofen market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Harbin Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS (IV) IBUPROFEN INDUSTRY
2.1 Summary about Intravenous (IV) Ibuprofen Industry
2.2 Intravenous (IV) Ibuprofen Market Trends
2.2.1 Intravenous (IV) Ibuprofen Production & Consumption Trends
2.2.2 Intravenous (IV) Ibuprofen Demand Structure Trends
2.3 Intravenous (IV) Ibuprofen Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pain/Inflammatory
4.2.2 Fever
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pediatrics
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pain/Inflammatory
5.2.2 Fever
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pediatrics
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pain/Inflammatory
6.2.2 Fever
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pediatrics
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pain/Inflammatory
7.2.2 Fever
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pediatrics
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pain/Inflammatory
8.2.2 Fever
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pediatrics
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pain/Inflammatory
9.2.2 Fever
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pediatrics
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Cumberland Pharmaceuticals
10.1.2 Alveda Pharmaceuticals
10.1.3 CSL Limited
10.1.4 Sandor Medicaids
10.1.5 PT. Soho Industri Pharmasi
10.1.6 Germin MED
10.1.7 Grifols
10.1.8 Harbin Gloria Pharmaceuticals
10.1.9 Al Nabeel International
10.1.10 Laboratorios Valmorca
10.2 Intravenous (IV) Ibuprofen Sales Date of Major Players (2017-2020e)
10.2.1 Cumberland Pharmaceuticals
10.2.2 Alveda Pharmaceuticals
10.2.3 CSL Limited
10.2.4 Sandor Medicaids
10.2.5 PT. Soho Industri Pharmasi
10.2.6 Germin MED
10.2.7 Grifols
10.2.8 Harbin Gloria Pharmaceuticals
10.2.9 Al Nabeel International
10.2.10 Laboratorios Valmorca
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Intravenous (IV) Ibuprofen Product Type Overview
2.Table Intravenous (IV) Ibuprofen Product Type Market Share List
3.Table Intravenous (IV) Ibuprofen Product Type of Major Players
4.Table Brief Introduction of Cumberland Pharmaceuticals
5.Table Brief Introduction of Alveda Pharmaceuticals
6.Table Brief Introduction of CSL Limited
7.Table Brief Introduction of Sandor Medicaids
8.Table Brief Introduction of PT. Soho Industri Pharmasi
9.Table Brief Introduction of Germin MED
10.Table Brief Introduction of Grifols
11.Table Brief Introduction of Harbin Gloria Pharmaceuticals
12.Table Brief Introduction of Al Nabeel International
13.Table Brief Introduction of Laboratorios Valmorca
14.Table Products & Services of Cumberland Pharmaceuticals
15.Table Products & Services of Alveda Pharmaceuticals
16.Table Products & Services of CSL Limited
17.Table Products & Services of Sandor Medicaids
18.Table Products & Services of PT. Soho Industri Pharmasi
19.Table Products & Services of Germin MED
20.Table Products & Services of Grifols
21.Table Products & Services of Harbin Gloria Pharmaceuticals
22.Table Products & Services of Al Nabeel International
23.Table Products & Services of Laboratorios Valmorca
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Intravenous (IV) Ibuprofen Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Intravenous (IV) Ibuprofen Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Intravenous (IV) Ibuprofen Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Intravenous (IV) Ibuprofen Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Intravenous (IV) Ibuprofen Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Intravenous (IV) Ibuprofen Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Intravenous (IV) Ibuprofen Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Intravenous (IV) Ibuprofen Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Intravenous (IV) Ibuprofen Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Intravenous (IV) Ibuprofen Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Intravenous (IV) Ibuprofen Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Pain/Inflammatory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Fever Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Pediatrics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Cumberland Pharmaceuticals 2017-2020e
60.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Alveda Pharmaceuticals 2017-2020e
61.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of CSL Limited 2017-2020e
62.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Sandor Medicaids 2017-2020e
63.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of PT. Soho Industri Pharmasi 2017-2020e
64.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Germin MED 2017-2020e
65.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Grifols 2017-2020e
66.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Harbin Gloria Pharmaceuticals 2017-2020e
67.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Al Nabeel International 2017-2020e
68.Figure Intravenous (IV) Ibuprofen Sales Revenue (Million USD) of Laboratorios Valmorca 2017-2020e
69.